Globeflex Capital L P trimmed its holdings in Heska Corporation (NASDAQ:HSKA) by 4.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,101 shares of the medical research company’s stock after selling 1,350 shares during the period. Heska Corporation comprises about 0.7% of Globeflex Capital L P’s investment portfolio, making the stock its 16th largest holding. Globeflex Capital L P owned about 0.37% of Heska Corporation worth $2,664,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. State of Wisconsin Investment Board acquired a new position in Heska Corporation in the second quarter valued at about $510,000. OppenheimerFunds Inc. bought a new stake in shares of Heska Corporation in the first quarter valued at about $451,000. Bank of New York Mellon Corp lifted its holdings in shares of Heska Corporation by 29.6% in the first quarter. Bank of New York Mellon Corp now owns 202,552 shares of the medical research company’s stock valued at $21,264,000 after purchasing an additional 46,231 shares in the last quarter. Marshall Wace North America L.P. bought a new stake in shares of Heska Corporation in the second quarter valued at about $4,847,000. Finally, Neuberger Berman Group LLC lifted its holdings in shares of Heska Corporation by 1.0% in the second quarter. Neuberger Berman Group LLC now owns 449,574 shares of the medical research company’s stock valued at $45,888,000 after purchasing an additional 4,329 shares in the last quarter. 81.36% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Heska Corporation (HSKA) Shares Sold by Globeflex Capital L P” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/heska-corporation-hska-shares-sold-by-globeflex-capital-l-p/1583137.html.

In other Heska Corporation news, CFO John Mcmahon sold 2,608 shares of Heska Corporation stock in a transaction dated Wednesday, August 30th. The stock was sold at an average price of $101.17, for a total transaction of $263,851.36. Following the completion of the transaction, the chief financial officer now owns 193 shares in the company, valued at approximately $19,525.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Nancy Wisnewski sold 825 shares of Heska Corporation stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $102.21, for a total value of $84,323.25. Following the transaction, the executive vice president now owns 38,114 shares of the company’s stock, valued at approximately $3,895,631.94. The disclosure for this sale can be found here. Company insiders own 14.70% of the company’s stock.

HSKA has been the topic of a number of research reports. Benchmark Co. restated a “buy” rating and issued a $120.00 price target (up from $106.00) on shares of Heska Corporation in a report on Wednesday, August 9th. Zacks Investment Research upgraded Heska Corporation from a “hold” rating to a “buy” rating and set a $109.00 price target on the stock in a report on Friday, August 4th. BidaskClub upgraded Heska Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 3rd. Aegis boosted their price target on Heska Corporation from $114.50 to $129.50 and gave the company a “buy” rating in a report on Tuesday, August 1st. Finally, B. Riley restated a “neutral” rating and issued a $96.50 price target on shares of Heska Corporation in a report on Thursday, August 3rd. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Heska Corporation has a consensus rating of “Hold” and an average target price of $105.20.

Shares of Heska Corporation (HSKA) traded down 0.13% during mid-day trading on Friday, hitting $89.36. The stock had a trading volume of 35,859 shares. The firm’s 50 day moving average price is $98.08 and its 200 day moving average price is $98.84. The company has a market cap of $645.72 million, a P/E ratio of 45.55 and a beta of 0.91. Heska Corporation has a 1-year low of $46.51 and a 1-year high of $115.00.

Heska Corporation (NASDAQ:HSKA) last issued its earnings results on Thursday, August 3rd. The medical research company reported $0.44 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.07. The company had revenue of $34.30 million during the quarter, compared to the consensus estimate of $33.35 million. Heska Corporation had a return on equity of 15.87% and a net margin of 10.70%. The firm’s revenue for the quarter was up 14.3% compared to the same quarter last year. During the same period last year, the business posted $0.35 EPS. Analysts predict that Heska Corporation will post $2.04 earnings per share for the current fiscal year.

Heska Corporation Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.